The angiotensin II receptor type 1b is the primary sensor of intraluminal pressure in cerebral artery smooth muscle cells

Journal of Physiology

Volumn 595, Issue 14, 2017, Pages 4735-4753

  Pires, Paulo W ^a   Ko, Eun A ^a   Pritchard, Harry A T ^a   Rudokas, Michael ^a   Yamasaki, Evan ^a   Earley, Scott ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

cation channel; GPCR; mechanosensitivity; myogenic response; vasoconstriction

Indexed keywords

9 PHENANTHROL; ANGIOTENSIN II RECEPTOR TYPE 1A; ANGIOTENSIN II RECEPTOR TYPE 1B; ANGIOTENSIN RECEPTOR; LOSARTAN; MESSENGER RNA; PROTEIN INHIBITOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL M4; UNCLASSIFIED DRUG; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRPM4 PROTEIN, MOUSE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTERIAL SMOOTH MUSCLE CELL; ARTICLE; CEREBRAL ARTERY SMOOTH MUSCLE CELL; CONTROLLED STUDY; ENZYME ACTIVATION; INTESTINE PRESSURE; MEMBRANE DEPOLARIZATION; MOUSE; NONHUMAN; PATCH CLAMP TECHNIQUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASOCONSTRICTION; YOUNG ADULT; ANIMAL; BRAIN ARTERY; C57BL MOUSE; CYTOLOGY; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; PHYSIOLOGY; PRESSURE; SMOOTH MUSCLE CELL;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CEREBRAL ARTERIES; LOSARTAN; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCYTES, SMOOTH MUSCLE; PRESSURE; RECEPTOR, ANGIOTENSIN, TYPE 1; TRPM CATION CHANNELS;

EID: 85020133208     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP274310     Document Type: Article

References (52)

1. Anfinogenova Y, Brett SE, Walsh MP, Harraz OF & Welsh DG (2011). Do TRPC-like currents and G protein-coupled receptors interact to facilitate myogenic tone development? Am J Physiol Heart Circ Physiol 301, H1378–H1388.
2. Bayliss WM (1902). On the local reactions of the arterial wall to changes of internal pressure. J Physiol 28, 220–231.
3. Blodow S, Schneider H, Storch U, Wizemann R, Forst AL, Gudermann T & Mederos y Schnitzler M (2014). Novel role of mechanosensitive AT1B receptors in myogenic vasoconstriction. Pflugers Arch 466, 1343–1353.
4. Bulley S, Neeb ZP, Burris SK, Bannister JP, Thomas-Gatewood CM, Jangsangthong W & Jaggar JH (2012). TMEM16A/ANO1 channels contribute to the myogenic response in cerebral arteries. Circ Res 111, 1027–1036.
5. Chen X, Li W, Yoshida H, Tsuchida S, Nishimura H, Takemoto F, Okubo S, Fogo A, Matsusaka T & Ichikawa I (1997). Targeting deletion of angiotensin type 1B receptor gene in the mouse. Am J Physiol Renal Physiol 272, F299–F304.
6. Cipolla MJ & Curry AB (2002). Middle cerebral artery function after stroke: the threshold duration of reperfusion for myogenic activity. Stroke 33, 2094–2099.
7. Daugherty A, Rateri DL, Lu H, Inagami T & Cassis LA (2004). Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation 110, 3849–3857.
8. Davis MJ & Hill MA (1999). Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 79, 387–423.
9. Earley S, Straub SV & Brayden JE (2007). Protein kinase C regulates vascular myogenic tone through activation of TRPM4. Am J Physiol Heart Circ Physiol 292, H2613–H2622.
10. Earley S, Waldron BJ & Brayden JE (2004). Critical role for transient receptor potential channel TRPM4 in myogenic constriction of cerebral arteries. Circ Res 95, 922–929.
11. Faraci FM, Lamping KG, Modrick ML, Ryan MJ, Sigmund CD & Didion SP (2006). Cerebral vascular effects of angiotensin II: new insights from genetic models. J Cereb Blood Flow Metab 26, 449–455.
12. Finnerty FA Jr, Witkin L & Fazekas JF (1954). Cerebral hemodynamics during cerebral ischemia induced by acute hypotension. J Clin Invest 33, 1227–1232.
13. Gasc JM, Shanmugam S, Sibony M & Corvol P (1994). Tissue-specific expression of type 1 angiotensin II receptor subtypes. An in situ hybridization study. Hypertension 24, 531–537.
14. Gonzales AL, Amberg GC & Earley S (2010a). Ca2+ release from the sarcoplasmic reticulum is required for sustained TRPM4 activity in cerebral artery smooth muscle cells. Am J Physiol Cell Physiol 299, C279–C288.
15. 2+ buffering is necessary for TRPM4 activity in cerebral artery smooth muscle cells. Cell Calcium 51, 82–93.
16. Gonzales AL, Garcia ZI, Amberg GC & Earley S (2010b). Pharmacological inhibition of TRPM4 hyperpolarizes vascular smooth muscle. Am J Physiol Cell Physiol 299, C1195–C1202.
17. Gonzales AL, Yang Y, Sullivan MN, Sanders L, Dabertrand F, Hill-Eubanks DC, Nelson MT & Earley S (2014). A PLCgamma1-dependent, force-sensitive signaling network in the myogenic constriction of cerebral arteries. Sci Signal 7, ra49.
18. Griffin SA, Brown WC, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany MJ & Lever AF (1991). Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 17, 626–635.
19. Harder DR (1984). Pressure-dependent membrane depolarization in cat middle cerebral artery. Circ Res 55, 197–202.
20. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O & Coffman TM (1995). Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci USA 92, 3521–3525.
21. Jepps TA, Bentzen BH, Stott JB, Povstyan OV, Sivaloganathan K, Dalby-Brown W & Greenwood IA (2014). Vasorelaxant effects of novel Kv 7.4 channel enhancers ML213 and NS15370. Br J Pharmacol 171, 4413–4424.
22. Jepps TA, Carr G, Lundegaard PR, Olesen SP & Greenwood IA (2015). Fundamental role for the KCNE4 ancillary subunit in Kv7.4 regulation of arterial tone. J Physiol 593, 5325–5340.
23. Kambayashi Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T & Inagami T (1993). Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem 268, 24543–24546.
24. Kitami Y, Okura T, Marumoto K, Wakamiya R & Hiwada K (1992). Differential gene expression and regulation of type-1 angiotensin II receptor subtypes in the rat. Biochem Biophys Res Commun 188, 446–452.
25. 2+] in cerebral arteries of rat by membrane potential and intravascular pressure. J Physiol 508, 199–209.
26. 2+-activated nonselective cation channel mediating cell membrane depolarization. Cell 109, 397–407.
27. + interstitial cells. J Physiol 592, 1283–1293.
28. Li Y, Baylie RL, Tavares MJ & Brayden JE (2014). TRPM4 channels couple purinergic receptor mechanoactivation and myogenic tone development in cerebral parenchymal arterioles. J Cereb Blood Flow Metab 34, 1706–1714.
29. Llorens-Cortes C, Greenberg B, Huang H & Corvol P (1994). Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension 24, 538–548.
30. Madhun ZT, Ernsberger P, Ke FC, Zhou J, Hopfer U & Douglas JG (1993). Signal transduction mediated by angiotensin II receptor subtypes expressed in rat renal mesangial cells. Regul Pept 44, 149–157.
31. Mederos y Schnitzler M, Storch U, Meibers S, Nurwakagari P, Breit A, Essin K, Gollasch M & Gudermann T (2008). Gq-coupled receptors as mechanosensors mediating myogenic vasoconstriction. EMBO J 27, 3092–3103.
32. 2+-activated cation channel TRPM4. J Biol Chem 278, 30813–30820.
33. Osol G, Brekke JF, McElroy-Yaggy K & Gokina NI (2002). Myogenic tone, reactivity, and forced dilatation: a three-phase model of in vitro arterial myogenic behavior. Am J Physiol Heart Circ Physiol 283, H2260–H2267.
34. Pires PW, Dams Ramos CM, Matin N & Dorrance AM (2013). The effects of hypertension on the cerebral circulation. Am J Physiol Heart Circ Physiol 304, H1598–H1614.
35. Pires PW, Jackson WF & Dorrance AM (2015). Regulation of myogenic tone and structure of parenchymal arterioles by hypertension and the mineralocorticoid receptor. Am J Physiol Heart Circ Physiol 309, H127–H136.
36. Rakesh K, Yoo B, Kim IM, Salazar N, Kim KS & Rockman HA (2010). β-Arrestin-biased agonism of the angiotensin receptor induced by mechanical stress. Sci Signal 3, ra46.
37. Reading SA & Brayden JE (2007). Central role of TRPM4 channels in cerebral blood flow regulation. Stroke 38, 2322–2328.
38. Rosenberg GA (1999). Ischemic brain edema. Prog Cardiovasc Dis 42, 209–216.
39. Sasamura H, Hein L, Krieger JE, Pratt RE, Kobilka BK & Dzau VJ (1992). Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome. Biochem Biophys Res Commun 185, 253–259.
40. Schleifenbaum J, Kassmann M, Szijarto IA, Hercule HC, Tano JY, Weinert S, Heidenreich M, Pathan AR, Anistan YM, Alenina N, Rusch NJ, Bader M, Jentsch TJ & Gollasch M (2014). Stretch-activation of angiotensin II type 1a receptors contributes to the myogenic response of mouse mesenteric and renal arteries. Circ Res 115, 263–272.
41. Scimia MC, Hurtado C, Ray S, Metzler S, Wei K, Wang J, Woods CE, Purcell NH, Catalucci D, Akasaka T, Bueno OF, Vlasuk GP, Kaliman P, Bodmer R, Smith LH, Ashley E, Mercola M, Brown JH & Ruiz-Lozano P (2012). APJ acts as a dual receptor in cardiac hypertrophy. Nature 488, 394–398.
42. Shanmugam S, Corvol P & Gasc JM (1994). Ontogeny of the two angiotensin II type 1 receptor subtypes in rats. Am J Physiol Endocrinol Metab 267, E828–E836.
43. Spassova MA, Hewavitharana T, Xu W, Soboloff J & Gill DL (2006). A common mechanism underlies stretch activation and receptor activation of TRPC6 channels. Proc Natl Acad Sci USA 103, 16586–16591.
44. Storch U, Mederos y Schnitzler M & Gudermann T (2012). G protein-mediated stretch reception. Am J Physiol Heart Circ Physiol 302, H1241–H1249.
45. Sugaya T, Nishimatsu S, Tanimoto K, Takimoto E, Yamagishi T, Imamura K, Goto S, Imaizumi K, Hisada Y, Otsuka A & et al (1995). Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem 270, 18719–18722.
46. Tian Y, Baukal AJ, Sandberg K, Bernstein KE, Balla T & Catt KJ (1996). Properties of AT1a and AT1b angiotensin receptors expressed in adrenocortical Y-1 cells. Am J Physiol Endocrinol Metab 270, E831–E839.
47. Welsh DG, Morielli AD, Nelson MT & Brayden JE (2002). Transient receptor potential channels regulate myogenic tone of resistance arteries. Circ Res 90, 248–250.
48. Xin HB, Deng KY, Rishniw M, Ji G & Kotlikoff MI (2002). Smooth muscle expression of Cre recombinase and eGFP in transgenic mice. Physiol Genomics 10, 211–215.
49. Yasuda N, Miura S, Akazawa H, Tanaka T, Qin Y, Kiya Y, Imaizumi S, Fujino M, Ito K, Zou Y, Fukuhara S, Kunimoto S, Fukuzaki K, Sato T, Ge J, Mochizuki N, Nakaya H, Saku K & Komuro I (2008). Conformational switch of angiotensin II type 1 receptor underlying mechanical stress-induced activation. EMBO Rep 9, 179–186.
50. Zhou J, Ernsberger P & Douglas JG (1993). A novel angiotensin receptor subtype in rat mesangium. Coupling to adenylyl cyclase. Hypertension 21, 1035–1038.
51. + channel openers in cerebral arteries from diabetic rats. Circ Res 81, 996–1004.
52. Zou Y, Akazawa H, Qin Y, Sano M, Takano H, Minamino T, Makita N, Iwanaga K, Zhu W, Kudoh S, Toko H, Tamura K, Kihara M, Nagai T, Fukamizu A, Umemura S, Iiri T, Fujita T & Komuro I (2004). Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat Cell Biol 6, 499–506.